Topic Highlight
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 7, 2008; 14(21): 3292-3300
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3292
Figure 1
Figure 1 Montage and legend as prepared by Dr. Adrian Reuben for “Landmarks in Hepatology”[3]. A: Jan Gösta Waldenström (right) with Dr Göran Bauer, President of the Swedish College of Physicians, Stockholm, c.1989 (courtesy of Dr. Frank Wollheim); B: Henry George Kunkel, Paris, 1979, being informed of his naming for the Lita Annenberg Hazxen Award (courtesy of Dr. Eng M Tan); C: Ian Reay Mackay, on the occasion of his Retirement Symposium in 1987 organized by the Walter and Eliza Hall Institute (courtesy of the subject). Reproduced by courtesy of Dr. Reuben and Wiley and Sons Inc., publishers of Hepatology).
Figure 2
Figure 2 Combined Figures 1 and 2 from a publication[35] on long-term prospective controlled trial of corticosteroid treatment of patients with active chronic (autoimmune) hepatitis. The graphs show duration of treatment and survival for (A), left, non-treated control group and (B), right, corticosteroid treated group, and length of time (months) that the individual patients in either group had been in the investigation at the time of assessment. Numbers indicate the sequence of entry to the trial; +, time of death. Survival was 19/22 for the treated group and 12/27 for the control group. Reproduced with permission of Oxford University Press, publishers of Quarterly Journal of Medicine.